Priming of Sorafenib Prior to Radiofrequency Ablation Does Not Increase Treatment Effect in Hepatocellular Carcinoma

Background Preclinical studies have shown that modulation of the tumor microvasculature with anti-angiogenic agents decreases tumor perfusion and may increase the efficacy of radiofrequency ablation (RFA) in hepatocellular carcinoma (HCC). Retrospective studies suggest that sorafenib given prior to...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Digestive diseases and sciences 2022-07, Vol.67 (7), p.3455-3463
Hauptverfasser:	Bockorny, Bruno, Bullock, Andrea J., Abrams, Thomas A., Faintuch, Salomao, Alsop, David C., Goldberg, S. Nahum, Ahmed, Muneeb, Miksad, Rebecca A.
Format:	Artikel
Sprache:	eng
Schlagworte:	Ablation Ablation (Surgery) Biochemistry Blood & organ donations Cancer Care and treatment Drug therapy Gastroenterology Hepatology Hepatoma Inhibitor drugs Liver cancer Magnetic resonance imaging Medical prognosis Medicine Medicine & Public Health Mortality Oncology Original Article Targeted cancer therapy Transplant Surgery Tumors
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!